Cilostazol: Clinical Trials

57 trials of Cilostazol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 11 unknown, 3 recruiting, 3 terminated. 57 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 457Completed 39, Unknown 11, Recruiting 3, Terminated 3, Not yet recruiting 1

Follow Cilostazol: new trials by email Literature Review of Cilostazol trials Research Report on Cilostazol

Trials (filtered) newest first · largest first

All 57 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Cilostazol, Aspirin - Type 2 Diabetes Mellitus (T2DM), Atherosclerosis
Phase 4RecruitingSeoul National University Bundang Hospital12002026-05-062026-07-22
Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol
Cilostazol, Aspirin, Clopidogrel - Cerebral Small Vessel Disease
Phase 4Not yet recruitingFirst Affiliated Hospital of Chengdu Medical College6322025-09-202025-09-23
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
Aspirin, Clopidogrel, Cilostazol - Cerebral Infarction, Stenosis Artery
Phase 4RecruitingAsan Medical Center23402025-07-102026-03-27
Clopidogrel Versus Cilostazol on Vessels
Clopidogrel, Cilostazol - Type 2 Diabetes, Atherosclerosis
Phase 4RecruitingSeoul National University Bundang Hospital1202024-04-162026-05-05
Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)
Cilostazol 100 MG, Placebo - Aneurysmal Subarachnoid Hemorrhage
Phase 4TerminatedHenry Ford Health System192019-11-012024-05-31
Cilostazol and Aspirin in Stroke and TIA
Cilostazol, Clopidogrel - Ischemic Stroke, TIA
Phase 4CompletedIncheon St.Mary's Hospital3782019-07-182024-08-06
Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm
Aspirin, Prasugrel, Clopidogrel - Aneurysm, Cerebral, Endovascular Procedures
Phase 4CompletedSeoul National University Hospital1982018-10-242022-04-27
Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study)
Triple antiplatelet therapy (aspirin (100 mg), clopidogrel (75 mg), and cilostazol (200 mg) ), Dual antiplatelet therapy (aspirin (100 mg) and clopidogrel (75 mg)) using aspirin and clopidogrel, Dual antiplatelet therapy (aspirin (100 mg) and cilostazol (200 mg)) using aspirin and cilostazol - Critical Limb Ischemia
Phase 4UnknownYonsei University3902017-02-212019-01-14
Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?
Clopidogrel, Cilostazol - Ischemic Stroke, Peripheral Artery Disease
Phase 4CompletedUniversity of Ioannina8262016-11-012020-12-29
Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients
Cilostazol, Acetylsalicylic acid - Type 2 Diabetes Mellitus
Phase 4UnknownKangbuk Samsung Hospital1162016-10-012016-10-14
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
Cilostazol, Aspirin - Type 2 Diabetes Mellitus, Carotid Atherosclerosis
Phase 4CompletedSeoul National University Bundang Hospital502016-09-262020-04-08
Cilostazol and Endothelial Progenitor Cell
Cilostazol Tablets, placebo, Aspirin - Myocardial Infarction, Acute
Phase 4UnknownGyeongsang National University Hospital602016-01-012020-05-29
Cilostazol After Lower Extremity Arterial Revascularization Trial
Cilostazol - Peripheral Arterial Disease, Claudication (Finding)
Phase 4TerminatedWake Forest University Health Sciences202015-02-012018-11-23
Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease
Cilostazol, Dummy Placebo - Coronary Artery Disease
Phase 4UnknownNational Cheng-Kung University Hospital3002014-02-012015-10-14
Cilostazol Stroke Prevention Study for Antiplatelet Combination
aspirin, clopidogrel, cilostazol - Noncardioembolic Cerebral Infarction
Phase 4CompletedJapan Cardiovascular Research Foundation18842013-12-132019-03-28
OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial
Clopidogrel, Cilostazol, Ticagrelor - Coronary Artery Disease
Phase 4CompletedThe First Affiliated Hospital with Nanjing Medical University17242013-10-052020-08-18
To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject
Atorvastatin, Probucol, Cilostazol - Severe Hypercholesterolemia
Phase 4CompletedOtsuka Beijing Research Institute3002013-10-012025-03-27
Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease
aspirin, cilostazol - Cerebral Small Vessel Disease
Phase 4UnknownInha University Hospital2552013-07-172019-08-08
Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in High Risk for Cardiovascular Disease
Cilostazol, Dummy Placebo - Cardiovascular Diseases
Phase 4CompletedNational Cheng-Kung University Hospital712013-01-012015-10-14
The Effect of Cilostazol Compared to Aspirin on Endothelial Function in Acute Cerebral Ischemia Patients
Cilostazol 100mg, Aspirin - Ischemic Stroke, Endothelial Dysfunction
Phase 4CompletedAjou University School of Medicine802012-03-012017-04-17

Showing 20 of 57. Sign in to see all of them.

Conditions studied

Diabetes Mellitus, Type 2 (9)  ·  Coronary Artery Disease (7)  ·  Cerebral Infarction (6)  ·  Ischemic Stroke (6)  ·  Peripheral Arterial Disease (5)  ·  Atherosclerosis (4)  ·  Acute Coronary Syndrome (3)  ·  Myocardial Infarction (3)  ·  Arteriosclerosis Obliterans (2)  ·  Brain Ischemia (2)  ·  Cardiovascular Diseases (2)  ·  Cerebral Small Vessel Diseases (2)  ·  Diabetic Nephropathies (2)  ·  Intermittent Claudication (2)  ·  Intracranial Hemorrhages (2)

Sponsors

Asan Medical Center (5)  ·  Otsuka Beijing Research Institute (4)  ·  Seoul National University Hospital (4)  ·  Gyeongsang National University Hospital (3)  ·  National Cheng-Kung University Hospital (3)  ·  Seoul National University Bundang Hospital (3)  ·  Shenyang Northern Hospital (3)  ·  Yonsei University (3)  ·  Korea Otsuka Pharmaceutical Co., Ltd. (2)  ·  Otsuka America Pharmaceutical (2)  ·  Ajou University School of Medicine (1)  ·  CardioVascular Research Foundation, Korea (1)  ·  China Medical University Hospital (1)  ·  Chinese University of Hong Kong (1)  ·  Colorado Prevention Center (1)

Countries

South Korea (28)  ·  China (9)  ·  United States (5)  ·  Japan (3)  ·  Philippines (3)  ·  Taiwan (3)  ·  Greece (1)  ·  Hong Kong (1)  ·  Thailand (1)

Top investigators

Ting-Hsing Chao, MD (3)  ·  Sun U. Kwon, MD, PhD (2)  ·  Boyd Richards, DO (1)  ·  Byung-Hee Oh, M.D. (1)  ·  Cheol Ho Kim, M.D. (1)  ·  Cheol Young Park, Professor (1)  ·  Chung Y. Hsu, MD. Ph.D. (1)  ·  Chunjian Li, Ph.D (1)  ·  Huang Yining, MD PhD (1)  ·  Hyeon-Cheol Gwon, MD, PhD (1)  ·  Hyo-Soo Kim, MD,PhD (1)  ·  In-Ho Chae, MD, PhD (1)  ·  In-Jin Jang, PhD (1)  ·  In-Suk Kim, MD.PhD. (1)  ·  Jae Hyeon Park, MD, PhD (1)

Results publications

PMID 35224730, PMID 17261652, PMID 22007612, PMID 22837373, PMID 24957314, PMID 27207972, PMID 35833913, PMID 10323786, PMID 11009277, PMID 11558482, PMID 11849859, PMID 12379573, PMID 12652104, PMID 16286167, PMID 17697815, PMID 18355656, PMID 18404599, PMID 18567918, PMID 19060422, PMID 19106084, PMID 19108880, PMID 19220726, PMID 19324253, PMID 19414633, PMID 19840579, PMID 19922880, PMID 19967051, PMID 20223369, PMID 20650435, PMID 20735821, PMID 20823393, PMID 20833591, PMID 21226953, PMID 21232664, PMID 21392640, PMID 21511217, PMID 21613787, PMID 21799173, PMID 22137075, PMID 22539545, PMID 22615190, PMID 22910894, PMID 23128968, PMID 23517020, PMID 23652861, PMID 23886346, PMID 23886748, PMID 24012432, PMID 24315720, PMID 24439986